Reumatologia naczyniowa: Miażdżyca i choroby układu kra̧żenia w zapaleniu stawów

Translated title of the contribution: Vascular rheumatology: Atherosclerosis and cardiovascular disease in arthritis

Z. Szekanecz, Edit Végh, Andrea Váncsa, Szilvia Szamosi, Z. Szabó, Nóra Bodnár, G. Szűcs, S. Szántó, P. Soltész, G. Kerekes

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Arthritides have been associated with accelerated atherosclerosis, increasing the risk of vascular disease. Traditional risk factors, as well as the role of systemic inflammation including activity of cytokines, chemokines, proteases, autoantibodies, adhesion molecules and others, have been implicated in the development of vascular diseases. Accelerated atherosclerosis and increased cardioand cerebrovascular morbidity and mortality have been observed in rheumatoid arthritis (RA) and spondyloarthropathies (SpA). Endothelial dysfunction, overt atherosclerosis and vascular stiffness may be indicated by brachial artery flow-mediated vasodilation (FMD), common carotid intima-media thickness (ccIMT) and aortic pulse-wave velocity (PWV), respectively. These abnormalities have been described in most inflammatory rheumatic diseases. While ccIMT and stiffness are relatively stable, FMD may be influenced by many confounding factors. In addition to traditional vasculoprotection, immunosuppressive agents including corticosteroids, traditional and biologic DMARDs may have significant vascular and metabolic effects. The official EULAR recommendations on the assessment and management of cardiovascular disease in arthritides have been published.

Original languageUndefined/Unknown
Pages (from-to)336-344
Number of pages9
JournalReumatologia
Volume50
Issue number4
Publication statusPublished - 2012

Fingerprint

Rheumatology
Arthritis
Blood Vessels
Atherosclerosis
Carotid Intima-Media Thickness
Cardiovascular Diseases
Vascular Diseases
Vasodilation
Spondylarthropathies
Pulse Wave Analysis
Vascular Stiffness
Antirheumatic Agents
Brachial Artery
Immunosuppressive Agents
Rheumatic Diseases
Chemokines
Autoantibodies
Rheumatoid Arthritis
Adrenal Cortex Hormones
Peptide Hydrolases

Keywords

  • Arthritis
  • Atherosclerosis
  • Biologics
  • Cardiovascular disease
  • Endothelial dysfunction

ASJC Scopus subject areas

  • Rheumatology

Cite this

Reumatologia naczyniowa : Miażdżyca i choroby układu kra̧żenia w zapaleniu stawów. / Szekanecz, Z.; Végh, Edit; Váncsa, Andrea; Szamosi, Szilvia; Szabó, Z.; Bodnár, Nóra; Szűcs, G.; Szántó, S.; Soltész, P.; Kerekes, G.

In: Reumatologia, Vol. 50, No. 4, 2012, p. 336-344.

Research output: Contribution to journalArticle

@article{98a2214f0dd24294802f5329ee9609bb,
title = "Reumatologia naczyniowa: Miażdżyca i choroby układu kra̧żenia w zapaleniu staw{\'o}w",
abstract = "Arthritides have been associated with accelerated atherosclerosis, increasing the risk of vascular disease. Traditional risk factors, as well as the role of systemic inflammation including activity of cytokines, chemokines, proteases, autoantibodies, adhesion molecules and others, have been implicated in the development of vascular diseases. Accelerated atherosclerosis and increased cardioand cerebrovascular morbidity and mortality have been observed in rheumatoid arthritis (RA) and spondyloarthropathies (SpA). Endothelial dysfunction, overt atherosclerosis and vascular stiffness may be indicated by brachial artery flow-mediated vasodilation (FMD), common carotid intima-media thickness (ccIMT) and aortic pulse-wave velocity (PWV), respectively. These abnormalities have been described in most inflammatory rheumatic diseases. While ccIMT and stiffness are relatively stable, FMD may be influenced by many confounding factors. In addition to traditional vasculoprotection, immunosuppressive agents including corticosteroids, traditional and biologic DMARDs may have significant vascular and metabolic effects. The official EULAR recommendations on the assessment and management of cardiovascular disease in arthritides have been published.",
keywords = "Arthritis, Atherosclerosis, Biologics, Cardiovascular disease, Endothelial dysfunction",
author = "Z. Szekanecz and Edit V{\'e}gh and Andrea V{\'a}ncsa and Szilvia Szamosi and Z. Szab{\'o} and N{\'o}ra Bodn{\'a}r and G. Szűcs and S. Sz{\'a}nt{\'o} and P. Solt{\'e}sz and G. Kerekes",
year = "2012",
language = "Undefined/Unknown",
volume = "50",
pages = "336--344",
journal = "Reumatologia",
issn = "0034-6233",
publisher = "Termedia Publishing House Ltd.",
number = "4",

}

TY - JOUR

T1 - Reumatologia naczyniowa

T2 - Miażdżyca i choroby układu kra̧żenia w zapaleniu stawów

AU - Szekanecz, Z.

AU - Végh, Edit

AU - Váncsa, Andrea

AU - Szamosi, Szilvia

AU - Szabó, Z.

AU - Bodnár, Nóra

AU - Szűcs, G.

AU - Szántó, S.

AU - Soltész, P.

AU - Kerekes, G.

PY - 2012

Y1 - 2012

N2 - Arthritides have been associated with accelerated atherosclerosis, increasing the risk of vascular disease. Traditional risk factors, as well as the role of systemic inflammation including activity of cytokines, chemokines, proteases, autoantibodies, adhesion molecules and others, have been implicated in the development of vascular diseases. Accelerated atherosclerosis and increased cardioand cerebrovascular morbidity and mortality have been observed in rheumatoid arthritis (RA) and spondyloarthropathies (SpA). Endothelial dysfunction, overt atherosclerosis and vascular stiffness may be indicated by brachial artery flow-mediated vasodilation (FMD), common carotid intima-media thickness (ccIMT) and aortic pulse-wave velocity (PWV), respectively. These abnormalities have been described in most inflammatory rheumatic diseases. While ccIMT and stiffness are relatively stable, FMD may be influenced by many confounding factors. In addition to traditional vasculoprotection, immunosuppressive agents including corticosteroids, traditional and biologic DMARDs may have significant vascular and metabolic effects. The official EULAR recommendations on the assessment and management of cardiovascular disease in arthritides have been published.

AB - Arthritides have been associated with accelerated atherosclerosis, increasing the risk of vascular disease. Traditional risk factors, as well as the role of systemic inflammation including activity of cytokines, chemokines, proteases, autoantibodies, adhesion molecules and others, have been implicated in the development of vascular diseases. Accelerated atherosclerosis and increased cardioand cerebrovascular morbidity and mortality have been observed in rheumatoid arthritis (RA) and spondyloarthropathies (SpA). Endothelial dysfunction, overt atherosclerosis and vascular stiffness may be indicated by brachial artery flow-mediated vasodilation (FMD), common carotid intima-media thickness (ccIMT) and aortic pulse-wave velocity (PWV), respectively. These abnormalities have been described in most inflammatory rheumatic diseases. While ccIMT and stiffness are relatively stable, FMD may be influenced by many confounding factors. In addition to traditional vasculoprotection, immunosuppressive agents including corticosteroids, traditional and biologic DMARDs may have significant vascular and metabolic effects. The official EULAR recommendations on the assessment and management of cardiovascular disease in arthritides have been published.

KW - Arthritis

KW - Atherosclerosis

KW - Biologics

KW - Cardiovascular disease

KW - Endothelial dysfunction

UR - http://www.scopus.com/inward/record.url?scp=84867528335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867528335&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84867528335

VL - 50

SP - 336

EP - 344

JO - Reumatologia

JF - Reumatologia

SN - 0034-6233

IS - 4

ER -